Company Filing History:
1 out of 1 
1 out of 497 Years Active: 2025
Title: Shanjie Rong: Innovator in Biotechnology
Introduction
Shanjie Rong is a prominent inventor based in Wuhan, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies and antigens. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Shanjie Rong's latest patents include groundbreaking research on phosphorylated antigens and antibodies. One of his notable patents focuses on a phosphorylated antigen at the SER23 site of the PGAM1 protein, along with methods for preparing antibodies directed to this antigen. This research is crucial in the field of biotechnology, as it provides insights into the preparation of antibodies that can specifically target phosphorylated proteins. Another significant patent involves the development of an anti-receptor expressed on lymphoid tissues (RELT) recombinant monoclonal antibody. This antibody has the biological activity of neutralizing the function of RELT, allowing for specific recognition and detection of RELT expression in various tissues and cells.
Career Highlights
Throughout his career, Shanjie Rong has worked with esteemed institutions such as Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in biotechnology.
Collaborations
Shanjie Rong has collaborated with notable colleagues, including Congyi Wang and Fei Sun. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Shanjie Rong's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical research and applications.